Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
KRYS

Market Cap: $10.23B

KI

Krystal Biotech, Inc.

KRYS

NASDAQ (NASDAQ Global Market)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin93.34%

EBITDA Margin49.59%

EBIT Margin48.43%

Pre-tax Margin51.45%

Net Profit Margin54.82%

Earnings Yield2.36%

Valuation Multiples

Price / Book7.54

Price / Sales23.22

Price / Earnings41.96

PEG0.68

Forward PEG1.76

EV / Sales22.27

EV / EBITDA44.91

EV / Operating Cash Flow36.02

EV / Free Cash Flow38.06

Price / Free Cash Flow39.68

Price / Operating Cash Flow37.62

Cash Flow & Capital

Free Cash Flow / Share$8.73

Operating Cash Flow / Share$9.22

Free Cash Flow Yield2.52%

Capex / Revenue3.30%

Capex / Operating Cash Flow5.34%

Capex / Depreciation2.33

Stock Compensation / Revenue9.43%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio8.32

Quick Ratio7.96

Cash Ratio3.36

Debt / Assets0.01

Debt / Capital0.01

Debt / Equity0.01

Long-Term Debt / Capital0.00

Debt / Market Cap0.00%

Net Debt / EBITDA-1.92

Solvency Ratio1.74

Financial Leverage1.10

Efficiency & Working Capital

Asset Turnover0.29

Fixed Asset Turnover2.74

Inventory Turnover0.64

Receivables Turnover3.18

Payables Turnover4.48

Days Sales Outstanding114.9

Days Inventory Outstanding566.73

Days Payables Outstanding81.41

Operating Cycle681.63

Cash Conversion Cycle600.22

Working Capital Turnover0.48

Returns & Quality

Return on Equity19.34%

Return on Assets16.09%

Return on Invested Capital14.39%

ROCE14.41%

Return on Tangible Assets16.09%

Operating Return on Assets13.66%

Income Quality1.13

Tax Burden1.07

Interest Burden1.06

Balance Sheet & Intrinsic Metrics

Enterprise Value$9.81B

Invested Capital$1.09B

Working Capital$932.25M

Tangible Asset Value$1.36B

Net Current Asset Value$918.13M

Graham Number$92.02

Graham Net-Net$28.14

Book Value / Share$46.03

Tangible Book Value / Share$46.03

Cash / Share$28.64

Financial Health Scores

Piotroski Score5

Altman Z-Score44.94

Revenue$440.48M

EBIT$213.33M

Market Cap$10.21B

Working Capital$932.25M

Retained Earnings$134.86M

Total Assets$1.5B

Total Liabilities$141.52M